"We are excited to see Pfizer advancing MesoC2 into clinical development rapidly, highlighting the potential of Nona's Harbour Mice® and integrated ADC platforms to deliver innovative cancer therapies ...
Tacrolimus is a mainstay immunosuppressant used to prevent rejection in kidney transplant recipients. However, its narrow therapeutic index necessitates routine monitoring, as intrapatient variability ...